Tiny-Z10 mg/5 ml

Tiny-Z is a mineral salt supplement that supplies elemental zinc. Its uses are classified below by strength of supporting evidence.

Established uses

• Treatment of zinc deficiency arising from inadequate dietary intake, malabsorption syndromes (e.g., chronic diarrhea, inflammatory bowel disease), increased losses (burns, protein-losing enteropathy), or increased requirement.
• Prevention of zinc deficiency in individuals at recognized risk, including some pregnant and lactating women and people with chronic malabsorptive disorders.

Guideline-supported adjunct use

• As an adjunct in the management of acute diarrhea in children, given together with oral rehydration therapy (ORT), consistent with WHO/UNICEF recommendations. Tiny-Z reduces the duration and severity of diarrheal episodes but does not replace fluid and electrolyte replacement with oral rehydration salts.

General/supplemental use

• General nutritional supplementation to maintain adequate zinc status during periods of increased need, such as growth, convalescence, or recovery from illness.

Zinc Sulfate Monohydrate is the monohydrate form of zinc sulfate (ZnSO₄·H₂O), a water-soluble inorganic zinc salt used to supply elemental zinc. In Bangladesh it is available as tablets, dispersible tablets, capsules, and oral liquid/syrup preparations, sometimes combined with folic acid or other minerals. Strength is usually expressed both as the salt weight and its equivalent elemental zinc content (for example, a common dispersible tablet strength provides roughly 20 mg of elemental zinc per dose).

Tiny-Z is a source of the essential trace mineral zinc. Zinc functions as a catalytic and structural cofactor for several hundred enzymes and is required for normal immune function, protein and nucleic acid synthesis, wound healing, growth and development, and taste and smell perception. Tiny-Z is used to correct or prevent zinc deficiency and, together with oral rehydration therapy, to shorten the duration and reduce the severity of acute diarrheal illness in children.

Trace element / mineral (nutritional) supplement — zinc salts

Zinc Sulfate Monohydrate dissociates in the gastrointestinal tract to release zinc ions, which are absorbed mainly in the small intestine via both carrier-mediated and passive processes; absorption efficiency decreases as intake increases and is reduced by phytates and by concurrent iron or calcium in high amounts. Zinc is a cofactor for enzymes such as carbonic anhydrase, alkaline phosphatase, RNA and DNA polymerases, and superoxide dismutase, and it stabilizes cell membranes and supports normal T-lymphocyte and neutrophil function. In diarrheal illness, zinc supplementation is believed to support enterocyte regeneration, restore mucosal barrier integrity, and improve intestinal water and electrolyte absorption, which together with oral rehydration therapy shortens illness duration.

Tiny-Z is for oral use. Tablets/capsules should be swallowed with water; dispersible tablets should be dissolved completely in a small amount of water before administration. Syrup/liquid forms should be measured with the calibrated spoon or cup provided. For best absorption, take on an empty stomach (1 hour before or 2 hours after meals); if gastric upset occurs, it may be taken with a small amount of food. Do not take at the same time as tetracycline or fluoroquinolone antibiotics (see Interactions).

Tiny-Z can form insoluble complexes with certain drugs in the gastrointestinal tract, reducing absorption of both agents. Clinically significant interactions include:

• Tetracyclines and fluoroquinolone antibiotics (e.g., doxycycline, ciprofloxacin): reduced absorption of both the antibiotic and zinc; separate administration by at least 2 hours before or 4–6 hours after the antibiotic.
• Penicillamine: reduced absorption of penicillamine; separate dosing by at least 1–2 hours.
• Iron and copper salts: zinc competes with iron and copper for intestinal absorption; concurrent high-dose use may reduce absorption of one or more minerals. Where combined supplementation is needed, spacing doses or physician-guided dose adjustment is advised.
• Phosphate-containing preparations and high-dose calcium: may reduce zinc absorption.

Chronic high-dose zinc supplementation can also cause copper deficiency over time (see Precautions and Warnings).

The most common adverse effects of Tiny-Z are gastrointestinal and are more likely when it is taken on an empty stomach:

• Nausea and vomiting
• Gastric irritation/epigastric discomfort, heartburn
• Abdominal cramps and diarrhea
• Metallic or unpleasant taste

These effects are usually dose-related and often improve by taking Tiny-Z with a small amount of food. Prolonged high-dose use can lead to copper deficiency and its associated effects (see Precautions and Warnings and Overdose Effects). Serious allergic reactions are rare.

Zinc is an essential nutrient in pregnancy and lactation, and standard supplemental doses of Tiny-Z at or near recommended dietary levels are generally considered acceptable and are often included as part of prenatal nutritional supplementation. However, doses above the recommended dietary allowance should be used only if clearly needed and if the potential benefit justifies the potential risk, and only under medical supervision, as data on high-dose supplementation in human pregnancy are limited. Zinc crosses the placenta and is excreted in breast milk; a physician should be consulted before using Tiny-Z at doses above standard nutritional supplementation during pregnancy or breastfeeding.

Use Tiny-Z with the following precautions:

• Copper deficiency: prolonged use of high-dose zinc without adequate copper intake can induce copper deficiency, which may present as anemia, neutropenia, or neurological symptoms; long-term high-dose therapy should be monitored by a physician.
• Not a substitute for oral rehydration therapy: in acute diarrhea, Tiny-Z is a proven adjunct that shortens illness duration but does not replace fluid and electrolyte replacement with oral rehydration salts.
• Gastric irritation: may cause stomach upset, especially on an empty stomach; can be taken with food if needed (see Side Effects).
• Drug spacing: separate administration from tetracyclines, fluoroquinolones, and penicillamine (see Interactions).
• Renal impairment: zinc is renally excreted; use with caution and physician guidance in significant renal impairment (see Use in Special Populations).

Acute overdose of Tiny-Z can cause nausea, vomiting, abdominal cramps, diarrhea, headache, and, in severe cases, lethargy and dizziness. Chronic excessive intake can cause copper deficiency, sideroblastic anemia, neutropenia, and impaired immune function. There is no specific home antidote; if overdose is suspected, seek immediate medical attention or contact a poison control center/emergency services. Management is supportive and should be carried out by trained medical personnel; do not attempt specific home treatment beyond seeking prompt medical care.

Store at room temperature (below 30°C), away from light and moisture. Keep out of reach of children.

Renal impairment: zinc is eliminated mainly via the gastrointestinal tract with a renal component; patients with significant renal impairment should use Tiny-Z only under medical supervision, with dose adjustment as advised by a physician.

Hepatic impairment: no well-established specific dose adjustment is required, but use should be guided by a physician in significant hepatic disease.

Elderly: no specific dose adjustment is generally required; monitor for gastrointestinal tolerability.

Pediatric and pregnant/lactating populations: see Pediatric Uses and Pregnancy and Lactation for detailed guidance.

Duration of Tiny-Z therapy depends on indication: for acute diarrhea in children, the WHO-recommended course is 10-14 days alongside oral rehydration therapy. For treatment of confirmed zinc deficiency, therapy is typically continued for 2-3 months or until deficiency is corrected, as guided by a physician and, where available, laboratory monitoring. For general nutritional supplementation, duration should follow the prescriber's advice.

Trace elements; mineral/nutritional supplements; antidiarrheal adjuncts (zinc salts)

Zinc Sulfate Monohydrate supplies zinc ions that act as an essential cofactor for numerous metalloenzymes and zinc-finger transcription factors involved in cell division, protein synthesis, and immune cell function. In diarrheal illness, zinc supports regeneration of intestinal epithelium and normalizes mucosal transport of water and electrolytes, complementing the fluid-replacing action of oral rehydration therapy.

Tiny-Z is used in children for two main purposes:

• Acute diarrhea (adjunct to ORT): per WHO/UNICEF guidance, 10 mg elemental zinc once daily for infants under 6 months, and 20 mg elemental zinc once daily for children 6 months to 5 years, for 10–14 days.
• Zinc deficiency treatment: weight-based dosing as outlined in Dosage and Administration, under medical supervision.

Safety and efficacy of doses above these established ranges have not been established in children, and long-term high-dose use should be avoided outside of physician guidance due to the risk of copper deficiency (see Precautions and Warnings).